Tag:
Targeted Genetics
Latest Headlines
Latest Headlines
Viral vector tech nets Targeted save
Genzyme last week aided in the rescue of Targeted Genetics, a developer of adeno-associated viral (AAV) vector technology. AAV is a naturally occurring virus unassociated with disease in humans.
Targeted Genetics survives near death experience
Seattle-based Targeted Genetics has survived a near death experience , selling intellectual property to Genzyme in exchange for $7 million--enough cash to fund its operations through next year.
Targeted Genetics does more cost-cutting
The struggling Targeted Genetics has decided to cut the lease at its Seattle headquarters to save funds. The company says it only has enough cash to continue operations into August. Its lease has
Targeted Genetics cuts staff in survival effort
Seattle-based Targeted Genetics is hunkering down into survival mode as it works through an 11th-hour effort to save the company. The developer is cutting its workforce from 35 down to 10 to 15,
Targeted Genetics faces bankruptcy
Despite making job and pay cuts, gene therapy company Targeted Genetics announced it will close up shop if it can't raise additional capital. In a statement, the company said that its "short cash
Targeted founder: Biotech needs to be more vocal
Over at Xconomy, Targeted Genetics founder and former CEO H. Stewart Parker offers up some advice to ensure a better future for biotech. If the sector is to survive the inevitable healthcare reform,
New round of layoffs, cost-cutting at biotechs
There's a slate of new belt-tightening moves at biotech companies.
In an effort to make sure it has cash on hand into June, Pressure BioSciences is closing a research facility in Rockville, MD and
Targeted Genetics reports tgAAC94 data
Targeted Genetics is reporting results from an early-stage study of tgAAC94 for inflammatory arthritis. The drug uses a specially engineered virus to transport a gene. When working properly, the
Gene therapy helps improve sight of the blind
Two new human trials of a gene therapy for inherited blindness have demonstrated that injecting replacement genes under the retinas of the blind can spur at least partial sight in some volunteers. In
Gene therapy trial to resume after patient's death
The gene therapy field is breathing a mighty sigh of relief  after Targeted Genetics
